SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-24-000103
Filing Date
2024-06-27
Accepted
2024-06-27 16:27:48
Documents
18
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20240627.htm   iXBRL 8-K 35263
2 EX-99.1 a2024_prx0627xnewdirecto.htm EX-99.1 12164
7 a2024_prx0627xnewdirecto001.jpg GRAPHIC 287947
8 a2024_prx0627xnewdirecto002.jpg GRAPHIC 228311
9 a2024_prx0627xnewdirecto003.jpg GRAPHIC 191956
  Complete submission text file 0001599298-24-000103.txt   1184962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20240627.xsd EX-101.SCH 2161
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20240627_def.xml EX-101.DEF 14787
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20240627_lab.xml EX-101.LAB 26043
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20240627_pre.xml EX-101.PRE 15429
21 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20240627_htm.xml XML 2735
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 241079644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)